ESC Premium Access

Accurate and efficient non-invasive strategy for early identification of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism (InShape II study)

Congress Presentation

About the speaker

Professor Erik Klok

Leiden University Medical Center, Leiden (Netherlands (The))
7 presentations

2 more presentations in this session

Favourable safety profile of S62798, a potent TAFIa (activated thrombin-activatable fibrinolysis inhibitor) inhibitor, in first-in-man study in healthy subjects

Speaker: Mrs F. Petit Dop (Suresnes, FR)


De-escalation/discontinuation of oxygen-therapy and medication is feasible and safe in chronic thromboembolic pulmonary hypertension patients treated with balloon pulmonary angioplasty

Speaker: Doctor M. Kimura (Tokyo, JP)


Access the full session

Advances in Chronic Thromboembolic Pulmonary Hypertension

Speakers: Professor E. Klok, Mrs F. Petit Dop, Doctor M. Kimura

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb